Lipoic Acid for Progressive Multiple Sclerosis (MS)

NCT03161028 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

115

Enrollment

FED

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Lipoic acid
DRUG: Placebo

Sponsor

VA Office of Research and Development